PROCESS TO PREPARE A SOLID SUPPORT FOR A PROCATALYST FOR POLYMERIZATION OF OLEFINS

Abstract

A process for the preparation of a solid support for a procatalyst for olefin polymerization includes: providing a compound R.sup.4.sub.zMgX.sup.4.sub.2-z wherein: R.sup.4 is independently a linear, branched or cyclic hydrocarbyl independently selected from alkyl, alkenyl, aryl, aralkyl, or alkylaryl groups, or combinations thereof; X.sup.4 is independently fluoride, chloride, bromide or iodide; and 0<z<2; and contacting the compound R.sup.4.sub.zMgX.sup.4.sub.2-z with a silane compound Si(OR.sup.5).sub.4-n(R.sup.6).sub.n to obtain a Mg(OR.sup.1).sub.xX.sup.1.sub.2-x wherein: R.sup.1, R.sup.5 and R.sup.6 are each independently a linear, branched or cyclic hydrocarbyl independently selected from alkyl, alkenyl, aryl, aralkyl, alkoxycarbonyl or alkylaryl groups, or combinations thereof; X.sup.1 is independently fluoride, chloride, bromide or iodide; 0<n<4; 0<z<2; and 0<x<2; wherein an initiator compound, which is a ketone, a diketone, an ester, a diester, and/or a benzamide, is added during step B to obtain a solid support.

Claims

1. A process for the preparation of a solid support for a procatalyst suitable for preparing a catalyst composition for olefin polymerization, said process comprising: A) providing or preparing a compound R.sup.4.sub.zMgX.sup.4.sub.2-z wherein: R.sup.4 is independently a linear, branched or cyclic hydrocarbyl group independently selected from alkyl, alkenyl, aryl, aralkyl, or alkylaryl groups, or one or more combinations thereof; X.sup.4 is independently fluoride, chloride, bromide or iodide; and 0<z<2; and B) contacting the compound R.sup.4.sub.zMgX.sup.4.sub.2-z with a silane compound Si(OR.sup.5).sub.4-n(R.sup.6).sub.n to form a Mg(OR.sup.1).sub.xX.sup.1.sub.2-x wherein: R.sup.1, R.sup.5 and R.sup.6 are each independently a linear, branched or cyclic hydrocarbyl group independently selected from alkyl, alkenyl, aryl, aralkyl, alkoxycarbonyl or alkylaryl groups, or one or more combinations thereof; X.sup.1 is independently fluoride, chloride, bromide or iodide; n is in range of 0 to 4; 0<z<2; and 0<x<2; wherein an initiator compound, which is a ketone, a diketone, an ester, a diester, or a benzamide, is added during step B to obtain a solid support, wherein the initiator compound does not contain any heteroatom, nor is a phthalate.

2. The process according to claim 1, wherein the initiator compound is a ketone compound represented by Formula I or a diketone represented by Formula II, ##STR00004## wherein R1, R2, R3, and R4 are each independently a linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, or one or more combinations thereof.

3. The process according to claim 1, wherein the initiator compound is a mono ester represented by Formula III or a diester represented by Formulas IV, or V ##STR00005## wherein R5, R6, R7, R8, R9 and R10, are each independently a linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, or one or more combinations thereof.

4. The process according to claim 1, wherein the initiator compound is an amide represented by Formula VII ##STR00006## wherein R13, R14, and R15 are each independently a linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, or one or more combinations thereof.

5. The process according to claim 1, further comprising: C) activating the solid support obtained in B) by contacting the solid support obtained with an activating electron donor and/or an activating compound.

6. A solid support directly obtained by or obtainable by the process according to claim 1.

7. A process for the preparation of a procatalyst suitable for preparing a catalyst composition for olefin polymerization, said process comprising: I) providing a solid support or activated solid support according to claim 6; and II) reacting said solid support or activated solid support with a halogen-containing Ti-compound, optionally an activator prior to or simultaneously with the addition of an internal donor, and at least one internal electron donor to obtain said procatalyst.

8. The process according to claim 7, wherein during II) as activator and internal electron donor are added: N,N-dimethyl benzamide (BA-2Me) as activator and 9,9-bis(methoxymethyl)fluorene (Flu) as internal donor; or ethyl benzoate (EB) as activator and 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) as internal donor, or N,N-dimethyl benzamide (BA-2Me) as activator and Isopropylisopentyldimethoxypropane (IPIPEN) as internal donor.

9. A procatalyst directly obtained by or obtainable by the process according to claim 7.

10. The solid support or activated solid support according to claim 6, having an average particle size (or APS) of between 8 and 35 microns.

11. A catalyst system comprising a procatalyst according to claim 10, a co-catalyst and optionally at least one external electron donor.

12. A process for the preparation of polyolefins comprising the contacting of the catalyst system of claim 11 with at least one olefin, to prepare a polypropylene homopolymer or a mixture of propylene and at least one olefin, to prepare a propylene-olefin copolymer.

13. A polyolefin obtainable by the process according to claim 12.

14. A shaped article comprising the polyolefin according to claim 13.

Description

DETAILED DESCRIPTION OF INVENTION AND EMBODIMENTS

[0040] It has been surprisingly found that the properties of the procatalyst can be improved by an improved method for preparing a solid support for said procatalyst according to the first aspect of the present invention. The use of an initiator compound added during the synthesis of the support has shown to increase the yield and decrease the xylene solubles value of the final polymer obtained. Moreover, a decrease of the D50 was observed as well as an increase of the pore volume of the solid support.

[0041] In addition, it was found that several classes of initiator compounds considered (ketones, esters and benzamides) provides additional advantages, such as a decrease in the bulk density for ester compounds and benzamide compounds and an increase in the pore volume of the procatalyst for the ester compounds.

[0042] Accordingly the initiator compound is selected from the group consisting of a ketone, a diketone, an ester, a diester and a benzamide, wherein the initiator compound does not contain any heteroatom, nor is a phthalate.

[0043] In an embodiment as initiator compound a ketone compound represented by Formula I or a diketone represented by Formula II is used,

##STR00001##

[0044] wherein R1, R2, R3, and R4 are each independently a linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, and one or more combinations thereof, preferably as initiator compound a ketone is used selected from a the group consisting of methyl isobutyl ketone, acetophenone, methyl propyl ketone, di-isopropyl ketone, acetone and acetyl acetone. Methyl isobutyl ketone, acetophenone, methyl propyl ketone, di-isopropyl ketone, and acetone are according to Formula I and acetyl acetone is according to Formula II.

[0045] Preferably, each R1, R2, R3 and R4 groups are C1-C12, more preferably C1-C6 groups. Preferably R1 is an alkyl group (preferably C1-C6) and R2 is an alkyl group (preferably C1-C6) or an aryl group (preferably C6).

[0046] In an embodiment, as initiator compound a mono ester represented by Formula III or a diester represented by Formulas IV, V and VI,

##STR00002##

[0047] wherein R5, R6, R7, R8, R9 and R10 are each independently a linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, and one or more combinations thereof, preferably said initiator is selected from a the group consisting of butyl acetate, ethyl acetate, ethyl benzoate, diethylmalonate, and diethylsuccinate. Butyl acetate, ethyl acetate, and ethyl benzoate are according to Formula III, diethylmalonate is according to Formula IV, diethylsuccinate is according to Formula V. Preferably, each R5, R6, R7, R8, R9, and R10 groups are C1-C12, more preferably C1-C6 groups. Preferably R5 is methyl (C1).

[0048] In an embodiment, as an initiator compound an amide represented by Formula VII is used

##STR00003##

[0049] wherein R13, R14, and R15 are each independently selected linear, branched or cyclic hydrocarbyl group, which hydrocarbyl group is independently selected from alkyl, alkenyl, aryl, aralkyl, and one or more combinations thereof, preferably as initiator compound an benzamide is used selected from a the group consisting of N,N-dimethyl benzamide is used.

[0050] In an embodiment, said solid support obtained is activated using an activating electron donor and/or an activating compound. Preferably as activating electron donor an alkyl alcohol is used, such as methanol or ethanol being more preferred. Preferably as activating compound metal alkoxide such as titanium tetraethoxide being more preferred. Preferably ethanol and/or titanium tetraethoxide, more preferably ethanol, to obtain an activated solid support.

[0051] In an embodiment, the initiator may be: [0052] methyl isobutyl ketone (MIBK), in which R1 is isobutyl (C4) and R2 is methyl (C1), [0053] acetophenone (AcPh), in which R1 is phenyl (C6) and R2 is methyl (C1), [0054] methyl propyl ketone (MPK), in which R1 is n-propyl (C3) and R2 is methyl (C1), [0055] di-isopropyl ketone (DIPK), in which R1 is isopropyl (C3) and R2 is isopropyl (C3), [0056] acetone (Ac), in which R1 is methyl (C1) and R2 is methyl (C1), [0057] acetyl acetone (AcAc), in which R3 is methyl (C1) and R4 is methyl (C1), [0058] butyl acetate (BuAc), in which R5 is methyl (C1) and R6 is n-butyl (C4), [0059] ethyl acetate (EA), in which R5 is methyl (C1) and R6 is ethyl (C2), [0060] ethyl benzoate (EB), in which R5 is phenyl (C6) and R6 is ethyl (C2), [0061] diethylmalonate (DEM), in which R7 is ethyl (C2) and R8 is ethyl (C2), [0062] diethylsuccinate (DES), in which R9 is ethyl (C2) and R10 is ethyl (C2), [0063] N,N-dimethyl benzamide, in which R13 is phenyl (C6) and R14 and R15 are both methyl (C1), [0064] dimethylmalonate (DMM), in which R7 is methyl (C2) and R8 is methyl (C2), [0065] dimethylsuccinate (DMS), in which R9 is methyl (C2) and R10 is methyl (C2),

[0066] A process disclosing an activation of a regular solid support is described in detail in WO2015091984 A1 of the same applicant, page 23 line 3 to page 28, line 14, which complete section is incorporated here by reference.

[0067] In another aspect the invention relates to the solid support or activated solid support that is directly obtained by or obtainable by the process according to the first aspect.

[0068] In another aspect, the present invention relates to a process for the preparation of a procatalyst suitable for preparing a catalyst composition for olefin polymerization, said process comprising: [0069] I) providing a solid support or activated solid support according to the invention; and [0070] II) reacting said solid support or activated solid support with a halogen-containing Ti-compound, optionally an activator prior to or simultaneous with the addition of an internal donor, and at least one internal electron donor to obtain said procatalyst.

[0071] Accordingly suitable internal electron donor are an electron-donating compound containing one or more atoms of oxygen (O) and/or nitrogen (N) for example, the internal electron donor may be: [0072] 9,9-bis(methoxymethyl)fluorene (Flu). [0073] 4-[(ethoxycarbonyl)-(methyl)amino]pentan-2-yl ethyl carbamate (AB-OEt) [0074] 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) [0075] Isopropylisopentyldimethoxypropane (IPIPEN) [0076] Di-n-butyl-phthalate (DBP)

[0077] In an embodiment of said process for preparing a procatalyst during II) as activator and internal electron donor are added: [0078] N,N-dimethyl benzamide (BA-2Me) as activator and 9,9-bis(methoxymethyl)fluorene (Flu) as internal donor; or [0079] ethyl benzoate (EB) as activator and 4-[(ethoxycarbonyl)-(methyl)amino]pentan-2-yl ethyl carbamate (AB-OEt) or 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) as internal donor; or [0080] N,N-dimethyl benzamide (BA-2Me) as activator and Isopropylisopentyldimethoxypropane (IPIPEN) as internal donor.

[0081] In the claims, the word comprising does not exclude other elements or steps, and the indefinite article a or an does not exclude a plurality. The foregoing description provides embodiments of the invention by way of example only. The scope of the present invention is defined by the appended claims. One or more of the objects of the invention are achieved by the appended claims.

EXAMPLES

[0082] The present invention is further elucidated based on the Examples below which are illustrative only and not considered limiting to the present invention.

[0083] I) Dosage Regime of IC: Premixing of Grignard and Silane Compounds, Dosing Temperature of 0 C., Dosing Time 2 Hours

Example 1 (E1)

Summary

[0084] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor the same ester di butyl phthalate is used. Step B is carried out at a mole ratio DBP/Mg of 0.1, a dosing temperature for the DBP of 0 C. and a dosing time of the DBP of 2 hours.

[0085] Step A) Preparation of the Grignard Compound

[0086] This step was carried out according to the procedure presented in Example III of EP 1 222 214 B1, but in large scale. A stainless steel reactor of 16 l volume was filled with magnesium powder 280 g. The reactor was brought under nitrogen. The magnesium was heated at 80 C. for 1 hour, after which a mixture of dibutyl ether (DBE, 1.5 l) and n-chlorobutane (80 ml) was added. The temperature was raised to 75 C. and iodine (0.7 g) was added to the reaction mixture. After the colour of the iodine had disappeared, a mixture of dibutyl ether (10 l) and n-chlorobutane (1.1 l) was slowly added for 3 hour. The temperature of reaction mixture was kept in interval 76-78 C.

[0087] The reaction mixture was stirred for another 4 hours at 76 C. Then the stirring and heating were stopped and the solid material was allowed to settle for 48 hours. By decanting the solution above the precipitate, the solution of butylmagnesiumchloride in dibutyl ether (product A) with a concentration of 0.86 mol Mg/I was obtained in this step.

[0088] Step B) Preparation of the Support+Addition of IC

[0089] This step was carried out according to the procedure presented in Example I of EP 1 222 214 B1, except that during the dosing of the components a dibutyl phthalate solution was additionally dosed into the reactor. 250 ml of dibutyl ether was introduced to a 1.5 liter reactor. The reactor was fitted by propeller stirrer. The reactor was thermostated at 0 C.

[0090] The solution of the product A obtained on step A (240 ml, 0.206 mol Mg) and solution of tetraethoxysilane in DBE (30.4 ml of TES+88.6 ml of DBE; Si/Mg=0.66) were cooled to 5 C., and then were dosed simultaneously into reactor throughout mixing device with volume 0.45 ml supplied with a jacket. Dosing time was 120 min. Mixing device (minimixer) was cooled to 5 C. by means of cold water circulating in the device jacket. The contact time of reagents (product A and TES) was 14 s in the minimixer and the connecting tube between the minimixer and the reactor. Simultaneously the solution of dibutyl phthalate (DBP) in DBE (5.5 ml of dibutyl phthalate and 34.5 ml of DBE; mole ratio DBP/Mg=0.1) were dosed to reactor through a separate tube during 120 min. The stirring speed in the reactor was 350 rpm at the beginning of dosing and was gradually increased up to 425 rpm at the end of dosing stage.

[0091] After completion of the dosing the reaction mixture was heated up to 60 C. during 120 min and kept at this temperature for 1 hour. Then the stirring was stopped and the solid product was allowed to settle. The supernatant was removed by decanting. The solid substance was washed three times using 900 ml of heptane. As a result the about 30 g of solid product B was obtained, suspended in heptane.

[0092] Step C) Activation of the Support

[0093] The support is not activated

[0094] Step D) Preparation of the Procatalyst

[0095] A glass reactor with volume 0.3 l was brought under nitrogen and 125 ml of titanium tetrachloride was added into reactor. The suspension, containing c.a. 6 g of the solid product B in 15 ml of heptane, was added into reactor under stirring. Then the reaction mixture was heated up to 100 C. during 1 hour and after that 1.6 ml of dibutyl phthalate was added into reactor (DBP/Mg=0.15). Then the reaction mixture was heated up to 115 C. and kept at 115 C. for 105 min. Then the stirring was stopped and the solid product was allowed to settle. The supernatant was removed by decanting, after which the solid product was washed with chlorobenzene (125 ml) at 100 C. for 20 min. Then the washing solution was removed by decanting, after which a mixture of titanium tetrachloride (62.5 ml) and chlorobenzene (62.5 ml) was added. The reaction mixture was kept at 115 C. for 30 min, after which the solid product was allowed to settle, and the last treatment was repeated once again. The solid product obtained was washed five times using 150 ml of heptane at 60 C., solid procatalyst, suspended in heptane, was obtained.

[0096] Step E) Polymerization of Propylene

[0097] Polymerization of propylene was carried out in a stainless steel reactor (with a volume of 0.7 l) in heptane (300 ml) at a temperature of 70 C., total pressure 0.7 MPa and hydrogen presence (55 ml) for 1 hour in the presence of a procatalyst system comprising the procatalyst component according to step C, triethylaluminium and cyclohexylmethyldimethoxysilane (c-donor). The concentration of the procatalyst component was 0.033 g/l; the concentration of triethylaluminium was 4.0 mmol/l and the concentration of c-donor was 0.2 mmol/l. Data on the procatalyst performance at the propylene polymerization are presented in Table 1.

Example 2 (E2)

Summary

[0098] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor the same ester di butyl phthalate is used. This is similar to Example 1, the only difference being that step C) is carried out and that in step D) the activated support was used. Step B is carried out at a mole ratio DBP/Mg of 0.1, a dosing temperature for the DBP of 0 C. and a dosing time of the DBP of 2 hours.

[0099] Step C) Activation of the Support

[0100] Then we have done additional stage of support activation via treatment of product B with ethanol according to procedure proposed in EP 1661917A1. The 0.31 glass flask equipped with a mechanical agitator was filled with a slurry of 6 g of product B dispersed in 100 ml of heptane in inert nitrogen atmosphere at 0 C. Subsequently a solution of 0.96 ml ethanol in 20 ml of heptane was added at 0 C. for 1 hour, resulting in a ratio ethanol/Mg=0.4. After that the slurry was slowly heated to 30 C. in 90 min and kept at that temperature for another 2 hours. Finally the supernatant liquid was decanted from the solid reaction product, which was washed once with 150 ml of heptane at 30 C. As a result the product C (activated support) was obtained, suspended in 15 ml of heptane.

Example 3 (E3)

Summary

[0101] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is discussed below. Step B is carried out at a mole ratio EB/Mg of 0.1, a dosing temperature for the EB of 0 C. and a dosing time of the EB of 2 hours.

[0102] Step B) Preparation of the Support+Addition of IC

[0103] Preparation of the product B (support) was carried out as described in Example 1 except that during the dosing of the components a ethyl benzoate solution (2.96 ml of ethyl benzoate (0.1 EB/Mg) and 37 ml of DBE) was additionally dosed into the reactor instead of dibutyl phthalate solution.

Example 4 (E4)

Summary

[0104] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out as in Example 2. Step B is carried out as in Example 3. Step B is carried out at a mole ratio EB/Mg of 0.1, a dosing temperature for the EB of 0 C. and a dosing time of the EB of 2 hours.

Example 5 (E5)

Summary

[0105] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (mono-ketone, methyl isobutyl ketone or MIBK) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as disclosed below. Step B is carried out at a mole ratio MIBK/Mg of 0.1, a dosing temperature for the MIBK of 0 C. and a dosing time of the MIBK of 2 hours.

[0106] Step B) Preparation of the Support+Addition of IC

[0107] Preparation of the product B (support) was carried out as described in Example 1 except that methylisobutylketone was used instead of dibutyl phthalate (2.58 ml methylisobutylketone (MIBK) and 47 ml of DBE; mole ratio MIBK/Mg=0.1).

Example 6 (E6)

Summary

[0108] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (di-ketone, acetyl acetone or AcAc) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as disclosed below. Step B is carried out at a mole ratio AcAc/Mg of 0.1, a dosing temperature for the AcAc of 0 C. and a dosing time of the AcAc of 2 hours.

[0109] Step B) Preparation of the Support+Addition of IC

[0110] Preparation of the product B (support) was carried out as described in Example 1 except that acetylacetone was used instead of dibutyl phthalate (2.1 ml acetylacetone (AcAc) and 47 ml of DBE; mole ratio AcAc/Mg=0.1).

Example 7 (E7)

Summary

[0111] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound a ketone compound (di-ketone, acetyl acetone or AcAc) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out as in Example 2. Step B is carried out as in Example 23. Step B is carried out at a mole ratio AcAc/Mg of 0.1, a dosing temperature for the Ac of 0 C. and a dosing time of the Ac of 2 hours.

Example 8 (E8)

Summary

[0112] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (mono-ketone, methyl propyl ketone or MPK) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as disclosed below. Step B is carried out at a mole ratio MPK/Mg of 0.1, a dosing temperature for the IC of 0 C. and a dosing time of the MPK of 2 hours.

[0113] Step B) Preparation of the Support+Addition of IC

[0114] Preparation of the product B (support) was carried out as described in Example 1 except that methyl propyl ketone was used instead of dibutyl phthalate (2.2 ml methyl propyl ketone (MPK) and 48 ml of DBE; mole ratio MPK/Mg=0.1).

Example 9 (E9)

Summary

[0115] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound a ketone compound (mono-ketone, methyl propyl ketone or MPK) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out as in Example 2. Step B is carried out as in Example 8. Step B is carried out at a mole ratio MPK/Mg of 0.1, a dosing temperature for the MPK of 0 C. and a dosing time of the MPK of 2 hours.

Example 10 (E10)

Summary

[0116] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (mono-ketone, di isopropyl ketone DIPK) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as disclosed below. Step B is carried out at a mole ratio DIPK/Mg of 0.1, a dosing temperature for the DIPK of 0 C. and a dosing time of the DIPK of 2 hours.

[0117] Step B) Preparation of the Support+Addition of IC

[0118] Preparation of the product B (support) was carried out as described in Example 1 except that diisopropyl ketone was used instead of dibutyl phthalate (2.35 g diisopropyl ketone (DIPK) and 48 ml of DBE; mole ratio DIPK/Mg=0.1).

Example 11 (E11)

Summary

[0119] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound a ketone compound (mono-ketone, di isopropyl ketone DIPK) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out as in Example 2. Step B is carried out as in Example 10. Step B is carried out at a mole ratio DIPK/Mg of 0.1, a dosing temperature for the DIPK of 0 C. and a dosing time of the DIPK of 2 hours.

Example 12 (E12)

Summary

[0120] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as described in Example 3 except that during the dosing of the components 5.92 ml of ethyl benzoate were used instead of 2.96 ml (5.92 ml of EB and 34 ml of DBE, mole ratio EB/Mg=0.2). Step B is carried out at a mole ratio EB/Mg of 0.2, a dosing temperature for the EB of 0 C. and a dosing time of the EB of 2 hours.

Example 13 (E13)

Summary

[0121] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as described in Example 12 except that during the dosing of the components 1.48 ml of ethyl benzoate were used (1.48 ml of EB and 38.5 ml of DBE, mole ratio EB/Mg=0.05). Step B is carried out at a mole ratio EB/Mg of 0.05, a dosing temperature for the EB of 0 C. and a dosing time of the EB of 2 hours.

Example 14 (E14)

Summary

[0122] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as described in Example 12 except that during the dosing of the components 0.74 ml of ethyl benzoate were used (0.74 ml of EB and 39 ml of DBE, mole ratio EB/Mg=0.025). Step B is carried out at a mole ratio EB/Mg of 0.025, a dosing temperature for the EB of 0 C. and a dosing time of the EB of 2 hours.

Example 15 (E15)

Summary

[0123] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as described in Example 1 except that during the dosing of the components 22 ml of dibutyl phthalate were used instead of 5.5 ml (22 ml of dibutyl phthalate and 18 ml of DBE; mole ratio DBP/Mg=0.4). Step B is carried out at a mole ratio DBP/Mg of 0.4, a dosing temperature for the DBP of 0 C. and a dosing time of the DBP of 2 hours.

Comparative Example 1 (CE1)

Summary

[0124] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used in a ratio DBP/Mg of 0.15. Steps A), D) and E) were carried out as described in Example 1, step C was not carried out.

[0125] Step B) is discussed below.

[0126] Step B) Preparation of the Support

[0127] Preparation of the solid product B (support) was carried out as described in Example 1, except that dosing of a solution of dibutyl phthalate was not used, that is, the procedure of support syntheses was close to Example I of EP 1 222 214 E1.

Comparative Example 2 (CE2)

Summary

[0128] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used in a ratio DBP/Mg of 0.2. Steps A), D) and E) were carried out as described in Example 1, step C was not carried out.

[0129] Step B) is discussed below.

[0130] Step B) Preparation of the Support

[0131] Preparation of the solid product B (support) was carried out as described in Example 1, except that dosing of a solution of dibutyl phthalate was not used, that is, the procedure of support syntheses was close to Example I of EP 1 222 214 B1.

Comparative Example 3 (CE3)

Summary

[0132] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used in a ratio DBP/Mg of 0.25. Steps A), D) and E) were carried out as described in Example 1, step C was not carried out.

[0133] Step B) is discussed below.

Step B) Preparation of the Support

[0134] Preparation of the solid product B (support) was carried out as described in Example 1, except that dosing of a solution of dibutyl phthalate was not used, that is, the procedure of support syntheses was close to Example I of EP 1 222 214 B1.

Comparative Example 4 (CE4)

Summary

[0135] This example makes use of a butyl Grignard compound for the solid support. The support is activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used. Steps A), D) and E) were carried out as described in Example 1, step C was carried out according to Example 2. Step B) was carried out as in Comparative Example 1.

TABLE-US-00001 TABLE 1 Examples using a dosing temperature of 0 C. and time of 2 hours during step B using DBP as internal donor* IC Act. Yield Ex Form# [IC/Mg] Sup. SPAN Ti Yield per Ti XS BD E1 VI DBP[0.1] No 0.45 1.8 12.2 678 1.5 430 E2 VI DBP[0.1] Yes 0.61 1.8 15.8 878 1.7 415 E3 III EB[0.1] No 0.75 1.4 12.0 857 0.4 460 E4 III EB[0.1] Yes 0.57 1.5 14.4 960 0.4 435 E5 I MIBK[0.1] No 0.50 1.3 6.5 500 1.7 476 E6 II AcAc[0.1] No 0.50 2.1 8.0 381 1.8 302 E7 II AcAc[0.1] Yes 0.40 1.5 10.9 727 1.5 309 E8 I MPK[0.1] No 0.9 1.5 12.6 840 1.6 455 E9 I MPK[0.1] Yes 0.9 1.6 14.4 900 2.1 464 E10 I DIPK[0.1] No 0.6 1.5 11.4 760 1.9 463 E11 I DIPK[0.1] Yes 0.6 1.6 15.4 963 2.3 456 E12 III EB[0.2] No 0.5 1.5 11.0 733 1.9 n.d. E13 III EB[0.05] No 0.9 1.4 8.9 636 1.4 n.d. E14 III EB[0.025] No 0.3 1.6 7.5 469 1.8 n.d. E15 VI DBP[0.4] No 1.9 1.4 11.5 821 2.4 n.d. CE1 None No 0.50 1.4 6.5 464 2.4 440 CE2 None No 0.50 1.4 5.7 407 2.6 440 CE3 None No 0.50 1.3 5.1 392 2.9 430 CE4 none Yes 0.55 1.9 11.8 621 2.2 425 SPAN = (D90 D10)/D50 Ti = titanium content of procatalyst in wt. % based on the total weight of the procatalyst Yield = activity (yield of PP in kilograms per gram of procatalyst in 1 hour) used during polymerization Yield per Ti = yield of PP per gram of Ti in procatalyst XS = value for xylene solubles in wt. % based on the total weight of the polymer obtained BD = bulk density in gram per liter IC Act. Ex. Form# [IC/Mg] Sup. PVs SAss PVp SAp E1 VI DBP[0.1] No 0.006 5.8 0.24 185 E15 VI DBP[0.4] No n.d. n.d. n.d. n.d. E3 III EB[0.1] No 0.006 4.4 0.22 207 CE1 None No <0.001 <0.5 0.18 174 *PVss = Pore volume of the solid support (V) in cm.sup.3 per gram of the support PVp = Pore volume of the procatalyst (V) in cm.sup.3 per gram of the support SAss = Surface area of the solid support (S.sub.BET) in m.sup.2 per gram of the support SAp = Surface area of the procatalyst (S.sub.BET) in m.sup.2 per gram of the support

[0136] The tables above clearly show that both for the non-activated supports as for the activated support the present invention (addition of IC during support synthesis) achieves at least one of the following: i) an increase in yield, ii) an increase in yield per wt. % of titanium; iii) an increase in the pore volume and surface area of the solid support; iv) an increase in the pore volume and surface area of the resulting procatalyst.

[0137] By the addition of the initiator compound in Example 1, the ratio of DBP to Mg is increased from 0.15 to 0.25 (0.1 during step B as initiator compound and 0.15 during step D as internal electron donor). To review if the positive effects where not obtained purely because of the increase in amount of DPB but actually by the pre-dosing of DBP in the form of initiator compound, comparative examples 2 and 3 (CE2 and CE3) were carried out having a DBP/Mg of 0.2 and 0.25 wherein the full dose of DBP is as internal electron donor during step D. The result of an increase in the amount of DBP was a decrease in activity by 20-30% and a deterioration in stereospecificity compared to the optimal DBP/Mg=0.15. Without wishing to be bound by a particular theory, the present inventors believe that because DBP (and the other ICs) contain a carboxyl group, that carboxyl group will interact with BuMgCl and is converted into derivatives of secondary and tertiary alcohols. In the final procatalyst obtained, the initiator compound as such is no longer present, instead it is converted when carrying out is initiating action.

[0138] To study the optimal IC/Mg ratio used during step B several tests were carried out. When Example 15 is compared to Example 1 (and when both are compared to CE1), it is clear that when increasing the IC/Mg ratio from 0.1 to 0.4 the overall yield drops and the XS increases to the same level as no IC present. Hence an IC/Mg ratio of 0.1 is preferred over 0.4. When Example 12 is compared to Example 3 (and when both are compared to CE1), it is clear that when increasing the IC/Mg ratio from 0.1 to 0.2 the overall yield drops and the XS increases almost to the same level as no IC present. Hence an IC/Mg ratio of 0.1 is preferred over 0.2. When Examples 13 and 14 are compared to Example 3 (and when both are compared to CE1), it is clear that when decreasing the IC/Mg ratio from 0.1 to 0.05 or even 0.025 the overall yield drops and the XS increases almost to the same level as no IC present. Hence an IC/Mg ratio of 0.1 is preferred over 0.05 and 0.025.

[0139] An additional advantage of the present invention is an increase in the pore volume and specific surface area of supports and catalysts obtained in the presence of electron donor compounds. This advantage may be useful for the use of the catalysts obtained according to the invention in the process of copolymerization of propylene with other olefins. The increase in pore volume and specific surface, as well as an increase in the activity of catalysts, is achieved by introducing donor compounds as initiator compounds into the support during the support synthesis.

[0140] II) Dosage Regimen of IC: Premixing of Grignard and Silane Compounds, Dosing Temperature of 35 C., Dosing Time 5 Hours

Example 16 (E16)

Summary

[0141] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as discussed below. Step B is carried out at a mole ratio DBP/Mg of 0.1, a dosing temperature for the DBP of 35 C. and a dosing time of the DBP of 5 hours.

[0142] Step B) Preparation of the Support+Addition of IC

[0143] Preparation of the product B (support) was carried out as described in Example 1 except that on the dozing stage the temperature was 35 C. and the dozing time was 5 hour. 300 ml of dibutyl ether was introduced to a 1.5 liter reactor. The reactor was fitted by propeller stirrer and was thermostated at 35 C.

[0144] The solution of the product A obtained on step A (450 ml, 0.387 mol Mg) and solution of tetraethoxysilane in DBE (57 ml of TES+168 ml of DBE; Si/Mg=0.66) were cooled to 5 C., and then were dosed simultaneously into reactor throughout mixing device with volume 0.45 ml supplied with a jacket. Dosing time was 300 min. Mixing device (minimixer) was cooled to 5 C. by means of cold water circulating in the device jacket. The contact time of reagents (product A and TES) was 18.7 s in the minimixer and the connecting tube between the minimixer and the reactor. Simultaneously the solution of dibutyl phthalate (DBP) in DBE (10.3 ml of dibutyl phthalate and 39.7 ml of DBE; mole ratio DBP/Mg=0.1) were dosed to reactor through a separate tube during 300 min. The stirring speed in the reactor was 350 rpm at the beginning of dosing and was gradually increased up to 500 rpm at the end of dosing stage.

[0145] After completion of the dosing the reaction mixture was heated up to 60 C. during 30 min and kept at this temperature for 1 hour. Then the stirring was stopped and the solid product was allowed to settle. The supernatant was removed by decanting. The solid substance was washed three times using 500 ml of heptane. As a result the solid product B was obtained, suspended in heptane.

Example 17 (E17)

Summary

[0146] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out according to Example 2. Step B is carried out according to Example 16. Step B is carried out at a mole ratio IC/Mg of 0.1, a dosing temperature for the IC of 35 C. and a dosing time of the IC of 5 hours.

Example 18 (E18)

Summary

[0147] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (di-ester, di butyl phthalate or DBP) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out as discussed below. Step B is carried out according to Example 17. Step B is carried out at a mole ratio IC/Mg of 0.1, a dosing temperature for the IC of 35 C. and a dosing time of the IC of 5 hours. This differs from Example 6 by a different support activation.

[0148] Step C) Activation of the Support

[0149] Support activation of product B was carried out with ethanol and titanium tetraethoxide according to procedure close to procedure described in Ex.4 of EP 1661917A1. The 0.3 l glass flask equipped with a mechanical agitator was filled with a slurry of 6 g of product B dispersed in 100 ml of heptane in inert nitrogen atmosphere at 0 C. Subsequently a solution of 0.96 ml ethanol in 20 ml of heptane was added at 0 C. for 1 hour, resulting in a ratio ethanol/Mg=0.4. The reaction mixture kept at 0 C. for 30 min. Then the temperature was increased to 20 C. and a solution of 0.944 g titanium tetraethoxide (TET/Mg=0.1) in 20 ml of heptane was added for 1 hour. After that the slurry was heated to 30 C. in 30 min and kept at that temperature for another 3 hours.

[0150] Finally the supernatant liquid was decanted from the solid reaction product, which was washed once with 150 ml of heptane at 30 C. As a result the product C (activated support) was obtained, suspended in 15 ml of heptane.

Example 19 (E19)

Summary

[0151] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B is carried out as disclosed below. Step B is carried out at a mole ratio EB/Mg of 0.1, a dosing temperature for the EB of 35 C. and a dosing time of the EB of 5 hours.

[0152] Step B) Preparation of the Support+Addition of/C

[0153] Preparation of the product B (support) was carried out as described in Example 16 except that ethyl benzoate was used instead of dibutyl phthalate (5.3 ml of ethyl benzoate (EB) and 44.7 ml of DBE; mole ratio EB/Mg=0.1).

Example 20 (E20)

Summary

[0154] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out according to Example 2. Step B) was carried out as described in Example 18. Step B is carried out at a mole ratio EB/Mg of 0.1, a dosing temperature for the EB of 35 C. and a dosing time of the EB of 5 hours.

Example 21 (E21)

Summary

[0155] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (mono-ketone acetone or Ac) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio Ac/Mg of 0.1, a dosing temperature for the Ac of 35 C. and a dosing time of the Ac of 5 hours.

[0156] Step B) Preparation of the Support+Addition of IC

[0157] Preparation of the product B (support) was carried out as described in Example 16 except that acetone was used instead of dibutyl phthalate (2.81 ml of Ac and 47.2 ml of DBE; mole ratio Ac/Mg=0.1).

Example 22 (E22)

Summary

[0158] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a ketone compound (acetophenone or AcPh) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio AcPh/Mg of 0.1, a dosing temperature for the AcPh of 35 C. and a dosing time of the AcPh of 5 hours.

[0159] Step B) Preparation of the Support+Addition of IC Preparation of the product B (support) was carried out as described in Example 16 except that acetophenone was used instead of dibutyl phthalate (4.52 ml of acetophenone (AcPh) and 45.5 ml of DBE; mole ratio AcPh/Mg=0.1).

Example 23 (E23)

SUMMARY

[0160] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound a ketone compound (acetophenone or AcPh) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out according to Example 2. Step B) is carried according to Example 22. Step B is carried out at a mole ratio AcPh/Mg of 0.1, a dosing temperature for the AcPh of 35 C. and a dosing time of the AcPh of 5 hours.

Example 24 (E24)

SUMMARY

[0161] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (di-ester diethylmalonate or DEM) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio DEM/Mg of 0.1, a dosing temperature for the DEM of 35 C. and a dosing time of the DEM of 5 hours.

[0162] Step B) Preparation of the support+addition of IC

[0163] Preparation of the product B (support) was carried out as described in Example 16 except that diethylmalonate was used instead of dibutyl phthalate (6.2 g of diethylmalonate (DEM) and 44 ml of DBE; mole ratio DEM/Mg=0.1).

Example 25 (E25)

Summary

[0164] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (di-ester diethylsuccinate or DES) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio DES/Mg of 0.1, a dosing temperature for the DES of 35 C. and a dosing time of the DES of 5 hours.

[0165] Step B) Preparation of the Support+Addition of IC

[0166] Preparation of the product B (support) was carried out as described in Example 16 except that diethylsuccinate was used instead of dibutyl phthalate (6.74 g of diethylsuccinate (DES) and 44 ml of DBE; mole ratio DES/Mg=0.1).

Example 26 (E26)

Summary

[0167] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound a benzamide compound (N,N-dimethyl benzamide or BA) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio BA/Mg of 0.1, a dosing temperature for the BA of 35 C. and a dosing time of the BA of 5 hours.

[0168] Step B) Preparation of the Support+Addition of IC

[0169] Preparation of the product B (support) was carried out as described in Example 16 except that N,N-dimethylbenzamide was used instead of dibutyl phthalate (5.77 g of N,N-dimethylbenzamide (BA) and 45 ml of DBE; mole ratio BA/Mg=0.1).

Example 27 (E27)

Summary

[0170] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound a benzamide compound (N,N-dimethyl benzamide or BA) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out according to Example 2. Step B) is carried according to Example 26. Step B is carried out at a mole ratio BA/Mg of 0.1, a dosing temperature for the BA of 35 C. and a dosing time of the BA of 5 hours.

Example 28 (E28)

Summary

[0171] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. As initiator compound an ester compound (mono-ester butyl acetate or BuAc) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is not carried out. Step B) is carried out as discussed below. Step B is carried out at a mole ratio BuAc/Mg of 0.1, a dosing temperature for the BuAc of 35 C. and a dosing time of the BuAc of 5 hours.

[0172] Step B) Preparation of the Support+Addition of IC

[0173] Preparation of the product B (support) was carried out as described in Example 19 except that butyl acetate was used instead of ethyl benzoate (5.1 ml butyl acetate (BuAc) and 45 ml of DBE; mole ratio BuAc/Mg=0.1).

Example 29 (E29)

Summary

[0174] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester butyl acetate or BuAc) is used and as an internal donor di butyl phthalate is used. Steps A), D) and E) were carried as described in Example 1. Step C) is carried out according to Example 2. Step B) is carried according to Example 28. Step B is carried out at a mole ratio BuAc/Mg of 0.1, a dosing temperature for the BuAc of 35 C. and a dosing time of the BuAc of 5 hours.

Comparative Example 5 (CE5)

Summary

[0175] This example makes use of a butyl Grignard compound for the solid support. The support is not activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used. Steps A), D) and E) were carried out as described in Example 16, step C was not carried out. Step B) is discussed below.

[0176] Step B) Preparation of the Support

[0177] Preparation of the solid product B (support) was carried out as described in Example 16, except that dosing of a solution of dibutyl phthalate was not used, that is, the procedure of support syntheses was close to Example I of EP 1 222 214 B1.

Comparative Example 6 (CE6)

Summary

[0178] This example makes use of a butyl Grignard compound for the solid support. The support is activated. No initiator compound was used. As internal donor an ester compound (di-ester, di butyl phthalate or DBP) is used. Steps A), D) and E) were carried out as described in Example 16, step C was carried out according to Example 2. Step B) was carried out as in Comparative Example 5.

TABLE-US-00002 TABLE 2 Examples using a dosing temperature of 35 C. and time of 5 hours during step B, using DBP as internal donor Act. Yield Ex. Form# IC Sup. SPAN* Ti* Yield* per Ti* XS* BD* E16 VI DBP No 0.45 1.7 12.1 712 1.7 455 E17 VI DBP Yes 0.51 1.9 18.0 947 2.3 425 E18 VI DPB Yes.sup.# 0.50 2.0 16.0 800 3.3 440 E19 III EB No 1.3 1.6 12.7 794 2.0 475 E20 III EB Yes 1.2 1.7 15.3 900 2.1 465 E21 I Ac No 1.0 1.4 9.9 707 1.6 458 E22 I AcPh No 1.0 1.7 10.9 641 2.1 488 E23 I AcPh Yes 1.1 1.7 13.1 771 2.1 459 E24 IV DEM No 1.6 1.7 12.7 747 1.9 437 E25 V DES No 0.8 1.4 9.3 664 2.0 447 E26 VII BA No 0.85 1.2 10.4 867 1.8 470 E27 VII BA Yes 0.83 1.3 13.0 1000 1.8 464 E28 III BuAc No 1.1 1.5 9.5 633 2.0 427 E29 III BuAc Yes 0.9 1.4 11.3 807 2.0 415 CE5 None No 0.52 1.3 5.8 446 2.5 460 CE6 none Yes 0.50 2.0 11.5 575 2.6 450 Act. Ex. Form# IC Sup. PVss* SAss* PVp* SAp* E16 VI DBP No 0.01 1.4 0.17 155 E17 VI DBP Yes n.d. n.d. 0.19 180 E19 III EB No 0.02 9.3 0.33 198 E22 I AcPh No 0.016 32.4 n.d. n.d. E23 I AcPh Yes n.d. n.d. 0.2 220 CE5 None No n.d. n.d. 0.13 175 CE6 none Yes n.d. n.d. 0.15 195 .sup.#double activation with TET and ETOH

[0179] The tables above clearly show that both for the non-activated supports as for the activated support the present invention (addition of IC during support synthesis) achieves at least one of the following: i) an increase in yield, and ii) an increase in yield per wt. % of titanium, iii) an increase in the pore volume and/or surface area of the solid support; and iv) an increase in the pore volume and surface area of the resulting procatalyst.

[0180] Other methods of increasing the yield are also known, such as for example from EP 1661917 which the support was activated by ethanol as well as tetra exthoxy titanium. When comparing Example 18 with Example 17 it can be seen that for this procatalyst according to the invention, even with single activation of the support (E17) a similar or even better results are obtained that with a double activated support (E18) in terms of yield and XS. Hence with a simpler solution a similar/better result is obtained. III) Examples using a dosing temperature of 0 C. and time of 2 hours during step B, using different internal donors

Example 30 (E30)

Summary

[0181] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used; as an activator to the internal donor ethyl benzoate is used and as internal donor 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) is used.

[0182] Steps A), and E) were carried out as described in Example 1.

[0183] Step B is carried out as described in Example 3 except that during the dosing of the components 1.48 ml of ethyl benzoate were used (1.48 ml of EB and 38.5 ml of DBE, mole ratio EB/Mg=0.05). Step C) is carried out according to Example 2.

[0184] Step D) Preparation of the procatalyst+activator+ID

[0185] Preparation of the procatalyst was carried out using two donors: ethylbenzoate as donor-activator and amino benzoate (AB) as described below. A glass reactor with volume 0.3 l was brought under nitrogen and 100 ml of titanium tetrachloride was added into reactor. The suspension, containing 6 g of the activated solid product B in 15 ml of heptane, was added into reactor under stirring. Reaction mixture kept at the room temperature for 60 min. Then the reaction mixture temperature was started to raise up to 105 C. for 60 min and ethyl benzoate solution (1.68 g in 3 ml of toluene, EB/Mg=0.3) was dosed into reactor for 15 min from 20 to 50 C. Reaction mixture was kept at T=105 C. for 90 min. Then the stirring was stopped and the solid substance was allowed to settle. The supernatant was removed by decanting, after which the solid product was washed with chlorobenzene (120 ml) at 100 C. for 20 min. Then the washing solution was removed by decanting, after which a mixture of titanium tetrachloride (60 ml) and chlorobenzene (60 ml) was added. The reaction mixture was heated up to 105 C. and aminobenzoate solution (0.64 g in 3 ml of toluene, AB/Mg=0.05) was added. Reaction mixture kept at T=105 C. for 60 min. After which the solid substance was allowed to settle, supernatant was removed by decanting and the last treatment was repeated once again, except that 0.57 g AB was used (AB/Mg=0.045).

[0186] After that a mixture of titanium tetrachloride (60 ml) and chlorobenzene (60 ml) was added and reaction mixture was kept at T=105 C. for 30 min. The solid substance was allowed to settle, supernatant was removed by decanting and the solid procatalyst obtained was washed five times using 150 ml of heptane at 60 C.

Example 31 (E31)

Summary

[0187] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used; as an activator to the internal donor ethyl benzoate is used and as internal donor 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) is used.

[0188] Steps A), and E) were carried out as described in Example 1.

[0189] Step B) is carried out as described in Example 3 except that during the dosing of the components 0.74 ml of ethyl benzoate were used (0.74 ml of EB and 39 ml of DBE, mole ratio EB/Mg=0.025).

[0190] Step C) is carried out according to Example 2.

[0191] Step D is carried out according to Example 30.

Example 32 (E32)

Summary

[0192] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl acetate or EA) is used; as an activator to the internal donor N,N-dimethyl benzamide (BA-2Me) is used and as internal donor 9,9-bis(methoxymethyl)fluorine (Flu) is used.

[0193] Steps A) and E) were carried out as described in Example 1.

[0194] Step B) is carried out according to Example 4.

[0195] Step C) is carried out according to Example 2.

[0196] Step D) is carried out as discussed below.

[0197] Step D) Preparation of the Procatalyst+Activator+ID

[0198] Preparation of the procatalyst was carried out using two another donors: benzamide (BA-2Me) as donor-activator and fluorene (Flu) as described below. A glass reactor with volume 0.3 l was brought under nitrogen and 120 ml of titanium tetrachloride was added into reactor. The suspension, containing 6 g of the activated solid product B in 15 ml of heptane, was added into reactor under stirring. Reaction mixture kept at the room temperature for 60 min. The reactor was heated to 100 C. and 0.87 g of N,N-dimethylbenzamide (BA-2Me/Mg=0.15 molar ratio) in 2 ml of chlorobenzene was added to reactor. The reaction mixture was kept at 105 C. for 10 min and 1.31 g of 9,9-bis-methoxymethyl-9H-fluorene (flu/Mg=0.132 molar ratio) in 3 ml of chlorobenzene was added to reactor. The reaction mixture was kept at 105 C. for 90 min. Then the stirring was stopped and the solid substance was allowed to settle. The supernatant was removed by decanting, after which the solid product was washed with chlorobenzene (120 ml) at 100 C. for 20 min. Then the washing solution was removed by decanting, after which a mixture of titanium tetrachloride (60 ml) and chlorobenzene (60 ml) was added. The reaction mixture was kept at 105 C. for 60 min, after which the solid substance was allowed to settle. The supernatant was removed by decanting, and the last treatment was repeated twice. The solid substance obtained was washed five times using 150 ml of heptane at 60 C., after which the procatalyst component, suspended in heptane, was obtained.

Example 33 (E33)

Summary

[0199] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used; as an activator to the internal donor N,N-dimethyl benzamide (BA-2Me) is used and as internal donor 9,9-bis(methoxymethyl)fluorine (Flu) is used.

[0200] Steps A) and E) were carried out as described in Example 1.

[0201] Step B) is carried out according to Example 3.

[0202] Step C) is carried out according to Example 2.

[0203] Step D) is carried out as according to Example 32.

Example 34 (E34)

Summary

[0204] This example makes use of a butyl Grignard compound for the solid support. The support is activated. As initiator compound an ester compound (mono-ester, ethyl benzoate or EB) is used; as an activator to the internal donor N,N-dimethyl benzamide (BA-2Me) is used and as internal donor Isopropylisopentyldimethoxypropane (IPIPEN) is used. Steps A) and E) were carried out as described in Example 1.

[0205] Step B) is carried according to Example 3.

[0206] Step C) is carried out according to Example 18.

[0207] Step D) is carried out as discussed below.

[0208] Step D) Preparation of the Procatalyst+Activator+ID

[0209] Preparation of the procatalyst was carried out using two another donors: benzamide (BA-2Me) as donor-activator and isopropylisopentyldimethoxypropane (IPIPEN) as described below. A glass reactor with volume 0.3 l was brought under nitrogen and 138 ml of titanium tetrachloride was added into reactor. The suspension, containing 5.5 g of the activated solid product B in 10 ml of heptane, was added into reactor under stirring. Reaction mixture kept at the room temperature for 60 min. The reactor was heated to 100 C. and 0.96 g of N,N-dimethylbenzamide (BA-2Me/Mg=0.16 molar ratio) in 3 ml of chlorobenzene was added to reactor. The reaction mixture was kept at 100 C. for 10 min and 0.61 g of isopropylisopentyldimethoxypropane (IPIPEN/Mg=0.074 molar ratio) in 3 ml of chlorobenzene was added to reactor. The reaction mixture was kept at 100 C. for 90 min. Then the stirring was stopped and the solid substance was allowed to settle. The supernatant was removed by decanting, after which the solid product was washed with chlorobenzene (138 ml) at 100 C. for 20 min. Then the washing solution was removed by decanting, after which a mixture of titanium tetrachloride (69 ml) and chlorobenzene (69 ml) was added. Then 0.55 g of isopropylisopentyldimethoxypropane (IPIPEN/Mg=0.061 molar ratio) in 3 ml of chlorobenzene was added to reactor. The reaction mixture was kept at 105 C. for 60 min, after which the solid substance was allowed to settle. The supernatant was removed by decanting, a mixture of titanium tetrachloride (69 ml) and chlorobenzene (69 ml) was added and the reaction mixture was kept at 105 C. for 60 min. After this solid substance was allowed to settle, the supernatant was removed by decanting and the last treatment was repeated one more time. The solid substance obtained was washed five times using 150 ml of heptane at 60 C., after which the procatalyst component, suspended in heptane, was obtained.

Comparative Example 7 (CE7)

Summary

[0210] This example makes use of a butyl Grignard compound for the solid support. The support is activated. No initiator compound was used; as an activator to the internal donor ethyl benzoate is used and as internal donor 4-[benzoyl(methyl)-amino]pentan-2-yl benzoate (AB) is used.

[0211] Steps A) and E) were carried out as described in Example 1.

[0212] Step B) is carried out according to Comparative Example 1.

[0213] Step C) is carried out according to Example 2.

[0214] Step D) is carried out according to Example 30.

Comparative Example 8 (CE8)

Summary

[0215] This example makes use of a butyl Grignard compound for the solid support. The support is activated. No initiator compound was used; as an activator to the internal donor N,N-dimethyl benzamide (BA-2Me) is used and as internal donor 9,9-bis(methoxymethyl)fluorine (Flu) is used.

[0216] Steps A) and E) were carried out as described in Example 1.

[0217] Step B) is carried out according to Comparative Example 1.

[0218] Step C) is carried out according to Example 2.

[0219] Step D) is carried out according to Example 32.

Comparative Example 9 (CE9)

Summary

[0220] This example makes use of a butyl Grignard compound for the solid support. The support is activated. No initiator compound was used; as an activator to the internal donor N,N-dimethyl benzamide (BA-2Me) is used and as internal donor isopropylisopentyldimethoxypropane (IPIPEN) is used.

[0221] Steps A) and E) were carried out as described in Example 1.

[0222] Step B) is carried out according to Comparative Example 1.

[0223] Step C) is carried out according to Example 18.

[0224] Step D) is carried out according to Example 34.

TABLE-US-00003 TABLE 3 Examples using a dosing temperature of 0 C. and time of 2 hours during step B, using different internal donors IC ID Act. Yield Ex. Form# [IC/Mg] [Act] Sup. Ti Yield per Ti XS BD E30 III EB[0.05] AB [EB] Yes 3.2 11.4 356 2.6 480 E31 III EB[0.025] AB [EB] Yes 2.9 12.0 414 2.5 486 E32 III EA[0.1] Flu [Ba2Me] Yes 2.2 13.2 600 1.9 405 E33 III EB[0.1] Flu [Ba2Me] Yes 2.5 10.9 436 1.9 470 E34 III EB[0.1] IPIPEN [Ba2Me] Yes 2.4 15.2 633 1.6 470 CE7 none AB [EB] Yes 3.2 11.2 350 2.5 470 CE8 none Flu [Ba2Me] Yes 2.8 11.4 407 1.7 475 CE9 none IPIPEN [Ba2Me] Yes 3.1 13.2 426 1.7 469 IC ID Act. Ex. Form# [IC/Mg] [Act] Sup. SPAN PVp SAp E30 III EB[0.05] AB [EB] Yes 0.9 0.21 430 E31 III EB[0.025] AB [EB] Yes 0.8 0.19 440 E32 III EA[0.1] Flu [Ba2Me] Yes 0.82 0.31 287 E33 III EB[0.1] Flu [Ba2Me] Yes 0.80 0.20 350 E34 III EB[0.1] IPIPEN [Ba2Me] Yes 0.5 0.22 340 CE7 none AB [EB] Yes 0.5 0.14 230 CE8 none Flu [Ba2Me] Yes 0.6 0.14 220 CE9 none IPIPEN [Ba2Me] Yes 0.7 0.14 230

[0225] The table above clearly shows an increase in the pore volume and surface area of the resulting procatalyst, making those procatalysts very suitable for homo but also hetero-polymer as it require to be more porous in order to be more accessible to the different monomers.

[0226] Therefore, those procatalysts are very suitable to obtain co-polymer or terpolymers of polypropylene, with for example higher ethylene/rubber content.